ZYME Zymeworks Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$25,15
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$16,0052 haftanın en düşüğü
$31,3452 haftanın en yükseği
Piyasa Değeri (MRQ)
$1.80B
P/E (TTM)
-12.5
Hisse Başına Kâr (TTM)
$-2.02
Gelir (TTM)
$37M
rozetleriniz
52 Haftlık Aralık
$16–$31
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$41
P/E
-12.5
ROE
-72.3%
Net Kâr Marjı
-404.0%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ZYME Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$25.15
Piyasa Değeri (MRQ)
$1.80B
P/E (TTM)
-12.5
Hisse Başına Kâr (TTM)
$-2.02
Gelir (TTM)
$37M
ROE (TTM)
-72.3%
52 Haftlık Aralık
$16–$31
ZYME Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Zymeworks Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriBiotechnology
çalışanlar231
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$106M2020-12-31 → 2025-12-31
Hisse Başına Kâr$-1.082020-12-31 → 2025-12-31
Serbest Nakit Akışı$-35M2023-12-31 → 2025-12-31
Net kar marjı-404.0%2023-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ZYME | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -12.55Y ort. ≈-8.8 | ≈-8.8 | · | · | |
| F/S (TTM) | 48.45Y ort. ≈13.8 | ≈13.8 | 10.3 | Aşırı değerli | |
| F/D (MRQ) | 22.35Y ort. ≈4.0 | ≈4.0 | 3.7 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -14.95Y ort. ≈-24.0 | ≈-24.0 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -15.05Y ort. ≈-25.0 | ≈-25.0 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 22.65Y ort. ≈3.4 | ≈3.4 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ZYME | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -419.0%5Y ort. ≈-149.5% | ≈-149.5% | -588.2% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -87.3%5Y ort. ≈-149.5% | ≈-149.5% | -588.2% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -407.8%5Y ort. ≈-128.3% | ≈-128.3% | · | · | |
| Net Kâr Marjı (TTM) | -404.0%5Y ort. ≈-131.2% | ≈-131.2% | -507.2% | Zayıf | |
| ROA (TTM) | -37.2%5Y ort. ≈-21.0% | ≈-21.0% | -29.6% | En üst düzey | |
| ROE (TTM) | -72.3%5Y ort. ≈-29.5% | ≈-29.5% | -42.0% | En üst düzey | |
| ROIC | -35.1%5Y ort. ≈-35.7% | ≈-35.7% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ZYME | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 6.35Y ort. ≈5.6 | ≈5.6 | 9.6 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 1.15Y ort. ≈3.2 | ≈3.2 | 6.6 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ZYME | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 38.9%5Y ort. ≈274.4% | ≈274.4% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -36.4%5Y ort. ≈10.2% | ≈10.2% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 22.2% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ZYME | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.2 | ≈0.2 | 0.2 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 3.55Y ort. ≈2.8 | ≈2.8 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$458.7K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-16.9%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 5, 2026 | $-0.62 | $-0.50 | -25.1% |
| 31 Mart 2026 | May 6, 2026 | $-0.59 | $-0.20 | -201.3% |
| 31 Aralık 2025 | $-0.55 | $-0.42 | -29.5% | |
| 30 Eylül 2025 | $-0.26 | $-0.33 | 20.6% | |
| 30 Haziran 2025 | $0.03 | $-0.50 | 106.0% | |
| 31 Mart 2025 | $-0.30 | $-0.42 | 28.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $3.60 | $4.91 | $6.63 | · | · | |
| Revenue / Share | $1.41 | $1.01 | $1.10 | · | · | |
| Cash Flow / Share | $-0.44 | $-1.45 | $-1.72 | · | · | |
| Cash / Share | $0.55 | $0.96 | $2.25 | · | · | |
| EPS (TTM) | $-1.08 | $-1.62 | $-1.72 | $1.90 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | · | 75,767,778 | 75,337,168 | 75,171,020 | · | 76,128,531 | 76,392,593 | 76,214,833 | · | 70,575,773 | 67,281,028 | 66,739,308 | · | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | · | 75,775,214 | 77,378,449 | 75,226,387 | · | 76,157,101 | 76,396,217 | 76,248,158 | · | 70,575,773 | 67,284,511 | 66,742,030 | · | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.13 | $2.24 | · | $4.26 | $4.47 | $4.67 | · | $5.27 | $5.73 | $6.20 | · | $6.25 | $6.63 | $7.39 | · | $2.91 | |
| Revenue / Share | $0.06 | $0.03 | · | $0.36 | $0.63 | $0.36 | · | $0.21 | $0.25 | $0.13 | · | $0.23 | $0.10 | $0.53 | · | $0.04 | |
| Cash Flow / Share | · | $-0.61 | · | · | · | $-0.05 | · | · | · | $-0.49 | · | · | · | $-1.25 | · | · | |
| Cash / Share | $2.51 | $3.34 | · | $0.86 | $1.31 | $1.10 | · | $1.76 | $1.00 | $1.62 | · | $1.39 | $2.10 | $2.83 | · | $1.56 | |
| EPS (TTM) | $-2.02 | $-1.37 | · | $-0.85 | $-0.98 | $-1.50 | · | $-1.48 | $-1.50 | $-1.77 | · | $3.24 | $2.93 | $2.72 | · | $-3.83 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $81M | · | $134M | $123M | $93M | · | $62M | $63M | $50M | · | $462M | $448M | $446M | · | $30M | |
| Net Income TTM | $-150M | $-103M | · | $-63M | $-74M | $-114M | · | $-114M | $-113M | $-126M | · | $205M | $186M | $173M | · | $-224M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -12.9 | -18.3 | · | -20.1 | -12.8 | -7.9 | · | -8.5 | -5.7 | -5.9 | · | 2.0 | 2.9 | 3.3 | · | -1.6 | |
| P/S | 50.3 | 22.5 | · | 9.5 | 7.6 | 8.9 | · | 14.0 | 9.6 | 14.7 | · | 0.9 | 1.3 | 1.3 | · | 12.7 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| Earnings Yield | -7.7% | -5.5% | · | -5.0% | -7.8% | -12.6% | · | -11.8% | -17.6% | -16.8% | · | 51.1% | 33.9% | 30.1% | · | -62.3% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $106M | $76M | $76M | $412M | $27M |
| Faaliyet Kâr Marjı % | -87.3% | -179.7% | -181.6% | · | · |
| Net Gelir | $-81M | $-123M | $-119M | $124M | $-212M |
| Seyreltilmiş Hisse Başı Kâr | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 5.9 | 3.4 | 7.4 | · | · |
| Cari Oran | 1.1 | 1.4 | 7.1 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-35M | $-112M | $-121M | · | · |
Kurumsal Sahipler (13F) 212 dosya · $1.9B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
212
Tutulan Değer
$1.9B
Yeni pozisyonlar
22
Çıkan pozisyonlar
31
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 22 (-20 önceki Ç'ye göre) | 31 (0 önceki Ç'ye göre) | 59 (-16 önceki Ç'ye göre) | 73 (+13 önceki Ç'ye göre) | -2.0M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600.445.942 | 22.970.388 | 32,29% | Hisse senetleri |
| Rubric Capital Management LP | $182.980.000 | 7.000.000 | 9,84% | Hisse senetleri |
| BlackRock, Inc. | $111.121.925 | 4.251.030 | 5,98% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $109.342.391 | 4.182.953 | 5,88% | Hisse senetleri |
| BVF INC/IL | $95.388.572 | 3.649.142 | 5,13% | Hisse senetleri |
| VANGUARD GROUP INC | $61.315.382 | 2.328.727 | 3,30% | Hisse senetleri |
| MORGAN STANLEY | $58.325.141 | 2.231.260 | 3,14% | Hisse senetleri |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46.558.373 | 1.781.116 | 2,50% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.752.208 | 1.558.998 | 2,19% | Hisse senetleri |
| Assenagon Asset Management S.A. | $32.727.986 | 1.252.027 | 1,76% | Hisse senetleri |
| Nextech Invest Ltd. | $29.118.548 | 1.113.946 | 1,57% | Hisse senetleri |
| STATE STREET CORP | $28.445.966 | 1.088.216 | 1,53% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $25.995.770 | 994.955 | 1,40% | Hisse senetleri |
| CITADEL ADVISORS LLC | $23.895.516 | 914.136 | 1,29% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23.259.000 | 889.802 | 1,25% | Hisse senetleri |
| FMR LLC | $18.365.133 | 702.568 | 0,99% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $18.099.012 | 692.410 | 0,97% | Hisse senetleri |
| Prosight Management, LP | $17.629.705 | 674.434 | 0,95% | Hisse senetleri |
| Qube Research & Technologies Ltd | $15.516.443 | 593.590 | 0,83% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.332.236 | 510.032 | 0,72% | Hisse senetleri |
| Redmile Group, LLC | $12.851.836 | 491.654 | 0,69% | Hisse senetleri |
| Capricorn Fund Managers Ltd | $12.717.868 | 486.529 | 0,68% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $12.307.288 | 470.822 | 0,66% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.939.512 | 418.497 | 0,59% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $10.382.547 | 397.190 | 0,56% | Hisse senetleri |
| Hillsdale Investment Management Inc. | $10.009.581 | 382.922 | 0,54% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $8.897.088 | 340.363 | 0,48% | Hisse senetleri |
| Granahan Investment Management, LLC | $8.787.144 | 336.157 | 0,47% | Hisse senetleri |
| NORTHERN TRUST CORP | $8.392.849 | 321.073 | 0,45% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $7.997.401 | 319.385 | 0,43% | Hisse senetleri |
| Pictet Asset Management Holding SA | $7.446.189 | 308.187 | 0,40% | Hisse senetleri |
| PICTON MAHONEY ASSET MANAGEMENT | $7.092.908 | 271.343 | 0,38% | Hisse senetleri |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.849.243 | 223.766 | 0,31% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $5.726.515 | 219.071 | 0,31% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $5.677.573 | 217.199 | 0,31% | Hisse senetleri |
| SummitTX Capital, L.P. | $5.510.364 | 210.802 | 0,30% | Hisse senetleri |
| Man Group plc | $5.509.763 | 210.779 | 0,30% | Hisse senetleri |
| FEDERATED HERMES, INC. | $4.914.190 | 187.995 | 0,26% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $4.350.114 | 166.416 | 0,23% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.066.835 | 155.579 | 0,22% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.984.154 | 152.416 | 0,21% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $3.800.390 | 145.386 | 0,20% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $3.785.255 | 144.807 | 0,20% | Hisse senetleri |
| DIADEMA PARTNERS LP | $3.715.330 | 142.132 | 0,20% | Hisse senetleri |
| CITIGROUP INC | $3.435.868 | 131.441 | 0,18% | Hisse senetleri |
| Bank of New York Mellon Corp | $3.427.107 | 131.106 | 0,18% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.408.656 | 130.400 | 0,18% | Alım opsiyonu |
| XTX Topco Ltd | $3.290.425 | 125.877 | 0,18% | Hisse senetleri |
| Nuveen, LLC | $3.120.829 | 119.389 | 0,17% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $3.100.282 | 118.603 | 0,17% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 başvurular | 19 Kasım 2025 | 30,70% | Değişiklik | Yönetim kurulu kampanyası | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 başvurular | 28 Aralık 2022 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 28 içeriden öğrenenler · 12 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 12 Ocak 2026 A | 226.842 | 0 | 4 | $-3.337.929 |
| Kristin Stafford | EVP, Chief Financial Officer | 06 Nisan 2026 A | · | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 05 Ocak 2024 A | 6.503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 10 Mart 2023 M | 17.032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 06 Temmuz 2026 A | 133.852 | 0 | 1 | $-138.740 |
| Paul R Schneider | EVP, General Counsel | 13 Mayıs 2026 A | · | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 09 Nisan 2026 A | · | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 09 Nisan 2026 A | · | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 12 Ocak 2026 A | 48.497 | 0 | 3 | $-721.486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 12 Ocak 2026 M | 26.708 | 0 | 2 | $-475.562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 06 Ocak 2026 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 10 Kasım 2022 M | 14.449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Yönetim kurulu üyesi | 12 Ocak 2026 A | 488.500 | 0 | 0 | $0 |
| Alessandra Cesano | Yönetim kurulu üyesi | 12 Ocak 2026 A | · | 0 | 0 | $0 |
| Carlos Campoy | Yönetim kurulu üyesi | 12 Ocak 2026 A | · | 0 | 0 | $0 |
| Robert E Landry | Yönetim kurulu üyesi | 12 Ocak 2026 A | · | 0 | 0 | $0 |
| Kelvin Neu | Yönetim kurulu üyesi | 12 Ocak 2026 A | · | 0 | 0 | $0 |
| Susan Mahony | Yönetim kurulu üyesi | 12 Ocak 2026 A | · | 0 | 0 | $0 |
| Brian N Cherry | Yönetim kurulu üyesi | 12 Ocak 2026 A | · | 0 | 0 | $0 |
| EcoR1 Capital, LLC | Yönetim kurulu üyesi | 17 Ocak 2025 P | 15.720.161 | 0 | 0 | $0 |
| Nancy Davidson | Yönetim kurulu üyesi | 10 Aralık 2024 A | · | 0 | 0 | $0 |
| Neil Gallagher | Yönetim kurulu üyesi | 10 Aralık 2024 A | · | 0 | 0 | $0 |
| Derek John Michael Miller | Yönetim kurulu üyesi | 10 Aralık 2024 A | · | 0 | 0 | $0 |
| Troy Cox | Yönetim kurulu üyesi | 10 Aralık 2024 A | · | 0 | 0 | $0 |
| Kenneth J. Hillan | Yönetim kurulu üyesi | 07 Aralık 2023 A | · | 0 | 0 | $0 |
| Hollings Renton | Yönetim kurulu üyesi | 07 Aralık 2023 A | · | 0 | 0 | $0 |
| Natalie Sacks | Yönetim kurulu üyesi | 21 Aralık 2022 A | · | 0 | 0 | $0 |
| Lota S. Zoth | Yönetim kurulu üyesi | 21 Aralık 2022 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 31 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,32% | 59.315 NS | 31 Temmuz 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,38% | 59.314 SH | 02 Ekim 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,14% | 14.705 SH | 02 Ekim 2026 | Günlük |
| IBB · iShares Trust | 0,14% | 537.742 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,12% | 5.008 SH | 02 Ekim 2026 | Günlük |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,11% | 65.877 NS | 31 Temmuz 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 74.514 SH | 19 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,08% | 439.290 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 50.443 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,07% | 66.685 SH | 02 Ekim 2026 | Günlük |
| IWM · iShares Trust | 0,04% | 1.202.863 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 270.692 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,03% | 22.528 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 189.632 NS | 31 Temmuz 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 5.969 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 5.910 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 18.267 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 3.039 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 110.298 SH | 19 Ağustos 2026 | Günlük |
| TILT · FlexShares Trust | 0,01% | 5.508 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 70.572 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.968 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12.951 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14.406 SH | 10 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 8.364 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 130 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.508.613 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.085 SH | 19 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 1.999 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 5.753 SH | 11 Eylül 2026 | Günlük |
| SMMV · iShares Trust | · | 16.029 SH | 19 Ağustos 2026 | Günlük |
ZYME Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 18 analist
AL
Medyan hedef
$38.00
+51,1%
6 33,3%
Güçlü Al
11 61,1%
Al
1 5,6%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
14 analist · 2026-10-04Ortalama hedef $41.07 +63,3%
← Tüm hedeflerin altında
Mevcut fiyat $25.15
Düşük$32.00
Ortalama$41.07
Yüksek$60.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026